Enhabit, Inc./$EHAB

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Enhabit, Inc.

Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.

Ticker

$EHAB

Primary listing

NYSE

Industry

Health Care Providers & Services

Employees

10,700

ISIN

US29332G1022

Enhabit, Inc. Metrics

BasicAdvanced
$488M
-
-$2.76
1.21
-

What the Analysts think about Enhabit, Inc.

Majority rating from 8 analysts.
Hold

Bulls say / Bears say

Enhabit Inc's hospice segment demonstrated robust growth in Q4 2024, with net service revenue increasing by 13.1% and Adjusted EBITDA rising by 13.7% year-over-year, indicating strong operational performance and potential for continued expansion. (ehab.com)
The company successfully reduced its bank debt by $40 million in 2024, including a $10 million reduction in Q4, reflecting a commitment to strengthening its balance sheet and enhancing financial stability. (ehab.com)
Enhabit's strategic focus on payer innovation has led to 48% of home health non-Medicare visits being under improved-rate contracts, diversifying revenue streams and potentially increasing profitability. (ehab.com)
In Q4 2024, Enhabit reported a net loss of $46.0 million, translating to a loss per share of $0.92, significantly below analyst expectations and indicating financial challenges. (gurufocus.com)
The home health segment experienced a 4.3% decline in net service revenue in Q4 2024, primarily due to a 10.4% decrease in Medicare revenue, suggesting potential difficulties in maintaining Medicare patient volumes. (gurufocus.com)
Enhabit recorded a $107.9 million impairment of goodwill in Q3 2024, contributing to a net loss of $110.2 million for the quarter, raising concerns about asset valuation and financial health. (gurufocus.com)
Data summarised monthly by Lightyear AI. Last updated on 6 Jun 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $EHAB

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs